David Rovinsky, MD
Orthopaedic Surgery · Lihue, HINPI 1528163284
Payments from drug & device makers
Across 526 payments — averaging $2117.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$931K
- Zimmer Biomet$183K
- Orthalign Inc$364
- Johnson & Johnson$225
- Axogen$56
What the payments were for
- Royalty or licence$143,95113%
- Consulting fees$237,00021%
- Speaking & faculty fees$536,42448%
- Travel & lodging$171,05315%
- Food & beverage$12,5651%
- Other$12,8811%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 499 | $930,536 |
| Zimmer Biomet | 18 | $182,693 |
| Orthalign Inc | 4 | $364 |
| Johnson & Johnson | 4 | $225 |
| Axogen | 1 | $56 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REAL INTELLIGENCE$341,975
- Journey II$317,001
- Navio Surgical System$199,339
- NAVIO$143,047
- Journey II XR$112,711
- Journey II BCS$105,530
- Legion Revision$82,714
- POLARSTEM$75,325
- JII Unicondylar Knee System$56,428
- Journey II CR$54,908
- Journey Uni$42,724
- R3 ACETABULAR$37,080
- REDAPT Revision Hip System$28,332
- Legion$27,554
- R3$25,966
- REDAPT$23,442
- CORI$21,499
- Oxinium Hips$18,760
- KNEE3 Software$18,625
- JOURNEY II UK$14,500
How this compares
$1,113,875 in reported general payments places this provider in the 95th percentile of 83 orthopaedic surgery providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ibuprofen | 56 | $563 |
| Cefadroxil | 75 | $550 |
| Oxycodone Hcl | 72 | $323 |
| Ondansetron Hcl | 59 | $280 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Lihue
- Alyssa CarnegieLihue$2K
- Catherine ShinLihue$991
- Robert MedoffKailua$166.4M
- Cass NakasoneHonolulu$1M
- Darin AwayaHonolulu$445K
- Christian KikuchiHonolulu$142K
- Spencer ChangHonolulu$110K
- Paul MortonHonolulu$83K
- Gary OkamuraHonolulu$69K
- Andrew RichardsonHonolulu$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.